欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0368/001
药品名称
Tardyferon
活性成分
ferrous sulphate 80.0 mg
剂型
Prolonged-release tablet
上市许可持有人
Pierre Fabre Médicament Portugal, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Estonia (EE)
TARDYFERON
Croatia (HR)
Tardyferon 80 mg tablete s produljenim oslobađanjem
Netherlands (NL)
Italy (IT)
Latvia (LV)
Slovenia (SI)
许可日期
2010/10/19
最近更新日期
2023/03/29
药物ATC编码
B03AA07 ferrous sulfate
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
PIL FerroTardyferon - Type IAin B.II.b.2.c.1 (EN) Clean
Date of last change:2014/05/20
Final SPC
|
1.3.1%20SmPC%20Tardyferon%20PT_%20TypeII%20tooth%20&%20freq%20AE%20(003)EN_%20VP_Revised%20Oct%207th%202013%20FINAL%20clean[1]
Date of last change:2014/04/01
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase